Assaf Bash, VP, Managing Director, & Discovery at Edwards Lifesciences, and Ofer Gonen, CEO of Clal Biotechnology

Name: Assaf Bash, VP, Managing Director, & Discovery at Edwards Lifesciences, and Ofer Gonen, CEO of Clal Biotechnology — ISRAEL HEALTHCARE FORUM
Start: 2019-03-13T15:30:00-0400
End: 2019-03-13T17:30:00-0400
Location: Harvard Business School, Aldrich 211

Wednesday, March 13, 2019
3:30 PM 5:30 PM 15:30 17:30

Harvard Business School, Aldrich 211 (map)

Google Calendar ICS

Assaf Bash has led the Edwards Life Sciences (Israel) organization since 2010 and is responsible for new product development. He has tremendous experience in medical device development. Edwards is a global leader in patient-focused medical innovations for structural heart disease, critical care and surgical monitoring

Ofer Gonen is the CEO of Clal Biotechnology (CBI). Ofer has deep experience across biotechnology and serves on the boards of several healthcare companies. He gained his experience in R&D through the prestigious TALPIOT program of the Israeli Defense Forces, for which he was awarded the Israeli National Security Medal.